article thumbnail

Community Pharmacist Creates Book to Teach Children About the Importance of Vaccines

Pharmacy Times

The book aims to make the vaccination process less scary and allow more children to be vaccinated.

Vaccines 123
article thumbnail

STAT+: During the pandemic, were great vaccines bad business? A company-by-company review

STAT

A key factor in taming the pandemic was the creation of effective vaccines , which have saved millions of lives. You’d think developing a successful vaccine would be an unmitigated win, from a financial perspective. Merck, which saw its vaccine efforts fail twice, is up 56%.

Vaccines 143
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Listen: How blockbusters get made, new vaccines for RSV, and mRNA’s Q score

STAT

Journalist Nathan Vardi joins us to talk about his new book delving into the race to develop the lifesaving cancer drug now called Imbruvica, involving a Scientologist CEO and secretive investor seeking redemption after the worst trade of his life.

article thumbnail

What HCPs think about blood clots linked to COVID-19 vaccines

pharmaphorum

In the latest edition of What HCPs Think , CREATION.co’s Laura Marsh looks at what healthcare professionals are saying about blood clots linked to COVID-19 vaccines. This sudden increase is due to reports of rare blood clots in recipients of the COVID-19 vaccines developed by AstraZeneca and more recently Johnson & Johnson.

Vaccines 105
article thumbnail

Novavax begins late-stage trial of COVID-19 vaccine in the UK

pharmaphorum

Novavax has begun a late-stage trial of its experimental COVID-19 vaccine in the UK, which could support filings for a licence in the UK, EU and other countries. The UK government has already signed an agreement with the US biotech to buy 60 million doses of the vaccine in August if trials work out.

article thumbnail

STAT+: Pharmalittle: Pfizer and Valneva delay application for Lyme vaccine; Moderna adjusts price for Covid-19 shot

STAT

Or if you feel like hiding from the world, you could curl up with an e-book or binge-watch by the telly. … Moderna anticipates its updated Covid-19 vaccine to have a list price in a range of $110 to $130 per shot, Politico notes.  The Feeling social? Reach out to someone special. Well, whatever you do, have a grand time.

article thumbnail

BioNTech bites back after CureVac patent challenge

pharmaphorum

BioNTech has responded to a patent infringement lawsuit filed by fellow German biotech CureVac over its COVID-19 vaccine, saying it will “vigorously” defend itself. ” CureVac’s first attempt to develop a COVID-19 vaccine ended in failure, and it is now working on a second version with partner GSK.